OTHER GROUP COMPANIES
market

Natco Pharma update on lawsuit for Glatiramer Acetate Injection

Natco Pharma update on lawsuit for Glatiramer Acetate Injection

May 25, 2022 2:04 IST | capital market
Natco Pharma announced that Johnson & Johnsons and Momenta Pharmaceuticals has filed a lawsuit against NATCO and its marketing partner Mylan Pharmaceuticals Inc. (Mylan) & others alleging infringement of two old Patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate Injection. This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner, Mylan believe this is a meritless suit for a product that has been in the market for more than 5 years. Mylan and NATCO will strongly defend against this suit. Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity